LXE408
kinetoplastid-selective proteasome inhibitor oral antileishmanial in Ph. I in HV From 3M cmpd antiprolif. screen + opt. J. Med. Chem., Jul. 29, 2020 Novartis (GNF), San Diego, CA
Molecules of the Month - July 2020
Molecules of the Month
- A-1331852
- dotinurad (FYU-981)
- X-165
- "compound 38a"
- HTL22562
- "compound 23"
- MGS0274
- LXE408
- "compound 2"
- AB680
- "compound 18"
- ETX0282
- "compound 6g"
- EC2629